Aviv Pharma
Reno, US · Founded 2022 · Nevada corporation
Founders & leadership
JA
Jeffrey Alan GlazerNamed on SEC filing
RR
Robert Rene RabalaisNamed on SEC filing
RA
Ricardo Alberto HungriaNamed on SEC filing
PA
Philip Arthur EpsteinNamed on SEC filing
JD
Jeffrey David RosenbergNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$2.3M disclosed across 1 round · 2023
▶$2.3MraisedDec 2023 · 12 investors · PharmaceuticalsRule 506(c)
▶$2.3MraisedDec 2023 · 12 investors · Pharmaceuticals
Rule 506(c)Officers, directors & promoters on the filing
- Jeffrey Alan GlazerExecutive Officer, Director
- Robert Rene RabalaisDirector
- Ricardo Alberto HungriaDirector
- Philip Arthur EpsteinExecutive Officer, Director
- Jeffrey David RosenbergDirector
- Offering amount
- $4M
- Amount sold
- $2.3M
- Minimum investment
- $25K
- First sale
- Dec 2023
- Incorporated
- Corporation, Nevada, 2022
- Federal exemptions
- 06c
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Aviv Pharma raised?
- Aviv Pharma has disclosed $2.3M raised across 1 round.
- Where is Aviv Pharma headquartered?
- Aviv Pharma is headquartered in Reno, US.